Larry Green, PhD

CEO at Ablexis and AlivaMab Biologics

Speaker

Larry Green, Ph.D., is founder and CEO of Ablexis and AlivaMab Biologics. He brings over thirty years of experience in the development and use of transgenic mice for the discovery of human therapeutic antibodies, contributing to the discovery of nine approved antibody drugs to date. He is an inventor on more than 80 issued patents covering antibody technologies and therapeutic product candidates. He founded Ablexis in 2009, where he has led the design, creation, and evolution of the AlivaMab^® Mouse, including the most recently launched Generation 8 platform, and AlivaMab Biologics in 2018. Larry received his Ph.D. from the University of Wisconsin-Madison and completed postdoctoral work at the University of Colorado-Boulder and Stanford University.